YARW (Yarrow Bioscience) FCF Margin %: 69,659.79% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

YARW Yarrow Bioscience Inc YARW
13 GF Score
Price $26.22
View Full Analysis

What is Yarrow Bioscience FCF Margin %?

Yarrow Bioscience YARW -2.78% 13 FCF Margin % is 69,659.79% as of Jun. 2026. GuruFocus rates YARW with a GF Score™ of 13/100. Among 961 Biotechnology companies, Yarrow Bioscience ranks worse than 91.57% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Yarrow Bioscience's Free Cash Flow for the three months ended in Jun. 2026 was $67.57 Mil. Yarrow Bioscience's Revenue for the three months ended in Jun. 2026 was $0.10 Mil. Therefore, Yarrow Bioscience's FCF Margin % for the quarter that ended in Jun. 2026 was 69,659.79%.

As of today, Yarrow Bioscience's current FCF Yield % is -8.46%.

The historical rank and industry rank for Yarrow Bioscience's FCF Margin % or its related term are showing as below:

YARW' s FCF Margin % Range Over the Past 10 Years
Min: -6116.49   Med: 0   Max: 0
Current: -6116.49

YARW's FCF Margin % is ranked worse than
91.57% of 961 companies
in the Biotechnology industry
Industry Median: -77.76 vs YARW: -6116.49

Yarrow Bioscience FCF Margin % Related Terms

Yarrow Bioscience FCF Margin % Historical Data

* Premium members only.

The historical data trend for Yarrow Bioscience's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yarrow Bioscience FCF Margin % Chart

Yarrow Bioscience Annual Data
Trend Dec25
FCF Margin %
0.00

Yarrow Bioscience Quarterly Data
Jun25 Dec25 Mar26 Jun26
FCF Margin % 0.00 0.00 0.00 69,659.79

YARW vs CGTX, RANI, VRCA: FCF Margin % Comparison

For the Biotechnology subindustry, Yarrow Bioscience's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yarrow Bioscience FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Yarrow Bioscience's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Yarrow Bioscience's FCF Margin % falls into.


YARW
13GF Score
Yarrow Bioscience Inc YARW
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yarrow Bioscience FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Yarrow Bioscience's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=0/0
= %

Yarrow Bioscience's FCF Margin for the quarter that ended in Jun. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=67.57/0.097
=69,659.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 69,659.79% mean?
Yarrow Bioscience (YARW) has a FCF Margin % of 69,659.79% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Yarrow Bioscience and its competitors. According to the industry distribution chart, Yarrow Bioscience ranks #880 out of 961 companies in the Biotechnology industry, placing it in the top 91.6%.
Is Yarrow Bioscience's FCF Margin % too high?
Yarrow Bioscience's current FCF Margin % is 69,659.79%. Based on the distribution chart, Yarrow Bioscience ranks #880 out of 961 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Yarrow Bioscience has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Yarrow Bioscience's FCF Margin % compare to CGTX and RANI?
According to the Biotechnology industry distribution chart, Yarrow Bioscience ranks #880 out of 961 companies for FCF Margin %. This places Yarrow Bioscience in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Yarrow Bioscience and its competitors. Yarrow Bioscience's current FCF Margin % is 69,659.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yarrow Bioscience stock overvalued right now?
Yarrow Bioscience (YARW) has a current FCF Margin % of 69,659.79%. The current FCF Margin % is 69,659.79%. Yarrow Bioscience's overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Yarrow Bioscience (YARW), the current FCF Margin % is 69,659.79% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Yarrow Bioscience Business Description

Address 251 Little Falls Drive, County of New Castle, City of Wilmington, DE, USA, 19808
Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.
13GF Score

Get the complete analysis for YARW

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.22
Price